ERBB2 c.2045T>C ;(p.I682T)

Variant ID: 17-37879670-T-C

NM_004448.2(ERBB2):c.2045T>C;(p.I682T)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.

Plos One
Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS
Publication Date: 2018

Variant appearance in text: ERBB2: I682T
PubMed Link: 29698444
Variant Present in the following documents:
  • pone.0196434.s001.xlsx, sheet 1
  • pone.0196434.s001.xlsx, sheet 2
View BVdb publication page



Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations.

Bmc Cancer
Masago, Katsuhiro K; Fujita, Shiro S; Muraki, Miho M; Hata, Akito A; Okuda, Chiyuki C; Otsuka, Kyoko K; Kaji, Reiko R; Takeshita, Jumpei J; Kato, Ryoji R; Katakami, Nobuyuki N; Hirata, Yukio Y
Publication Date: 2015-11-16

Variant appearance in text: ERBB2: I682T
PubMed Link: 26572169
Variant Present in the following documents:
  • Main text
  • 12885_2015_Article_1925.pdf
View BVdb publication page



A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria.

Nature
Mbengue, Alassane A; Bhattacharjee, Souvik S; Pandharkar, Trupti T; Liu, Haining H; Estiu, Guillermina G; Stahelin, Robert V RV; Rizk, Shahir S SS; Njimoh, Dieudonne L DL; Ryan, Yana Y; Chotivanich, Kesinee K; Nguon, Chea C; Ghorbal, Mehdi M; Lopez-Rubio, Jose-Juan JJ; Pfrender, Michael M; Emrich, Scott S; Mohandas, Narla N; Dondorp, Arjen M AM; Wiest, Olaf O; Haldar, Kasturi K
Publication Date: 2015-04-30

Variant appearance in text: ERBB2: I682T
PubMed Link: 25874676
Variant Present in the following documents:
  • Main text
View BVdb publication page